dc.contributor.author |
Yang G |
|
dc.contributor.author |
Hamadeh I |
|
dc.contributor.author |
Katz J |
|
dc.contributor.author |
Riva A |
|
dc.contributor.author |
Lakatos, Péter |
|
dc.contributor.author |
Balla B |
|
dc.contributor.author |
Kósa, János |
|
dc.contributor.author |
Vaszilkó, Mihály Tamás |
|
dc.contributor.author |
Pelliccioni GA |
|
dc.contributor.author |
Davis N |
|
dc.contributor.author |
Langaee TY |
|
dc.contributor.author |
Moreb JS |
|
dc.contributor.author |
Gong Y |
|
dc.date.accessioned |
2018-12-19T11:48:24Z |
|
dc.date.available |
2018-12-19T11:48:24Z |
|
dc.date.issued |
2018 |
|
dc.identifier |
85040715031 |
|
dc.identifier.citation |
pagination=91-98;
journalVolume=33;
journalIssueNumber=1;
journalTitle=JOURNAL OF BONE AND MINERAL RESEARCH; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/6266 |
|
dc.identifier.uri |
doi:10.1002/jbmr.3285 |
|
dc.description.abstract |
Osteonecrosis of jaw (ONJ) is a rare but serious adverse drug side effect, mainly associated with the use of intravenous (IV) bisphosphonates (BPs). The purpose of this study was to identify genetic variants associated with ONJ in patients of European ancestry treated with IV BPs using a whole-exome sequencing (WES). The WES phase 1 included 44 multiple myeloma patients (22 ONJ cases and 22 controls) and WES phase 2 included 17 ONJ patients with solid tumors. Multivariable logistic regression analysis was performed to estimate the odds ratios (ORs) and 95% confidence intervals (CI) adjusting for age, gender and principal components for ancestry. Meta-analysis of WES phase 1 and 2 was performed to estimate the combined ORs. In silico analyses were then performed to identify expression quantitative loci (eQTL) single nucleotide polymorphisms (SNPs) that are in high linkage disequilibrium (LD) with the top SNPs. The associations of the potentially functional SNPs were replicated and validated in an independent case-control study of 48 patients of European ancestry treated with IV BPs (19 ONJ cases and 29 controls). The top SNPs in the exome-wide association meta-analysis were two SNPs on Chromosome 10: SIRT1 SNP rs7896005 and HERC4 SNP rs3758392 with identical OR of 0.07 (0.01-0.46) (p = 3.83*10-5 ). In the in silico functional analyses, two promoter region SNPs (rs7894483 and rs3758391) were identified to be in high LD with the index SNPs and are eQTLs for SIRT1 gene in whole blood in the GTEx database. The ORs were 0.30 (0.10-0.88), 0.26 (0.12-0.55), and 0.26 (0.12-0.55) for the WES top SNP rs7896005 and two promoter SNPs rs7894483 and rs3758391, respectively, in the replication sample. In summary, we identified the SIRT1/HERC4 locus on Chromosome 10 to be associated with IV BPs related ONJ and two promoter SNPs that might be the potential genetic markers for this association. This article is protected by copyright. All rights reserved. |
|
dc.relation.ispartof |
urn:issn:0884-0431 |
|
dc.title |
SIRT1/HERC4 Locus Associated with Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association Analysis |
|
dc.type |
Journal Article |
|
dc.date.updated |
2018-08-30T12:45:45Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
3267275 |
|
dc.identifier.wos |
WOS:000422723400013 |
|
dc.identifier.pubmed |
28856724 |
|
dc.contributor.department |
SE/AOK/K/I. Sz. Belgyógyászati Klinika |
|
dc.contributor.department |
SE/FOK/Arc- Állcsont- Szájsebészeti és Fogászati Klinika |
|
dc.contributor.institution |
Semmelweis Egyetem |
|